Column Group III Gp, Lp

Insider Reports History

Entity
Company
Location
1700 Owens Street, Suite 500, San Francisco, CA
Signature
/s/ The Column Group III GP, LP /s/ James Evangelista, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Column Group III Gp, Lp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tenaya Therapeutics, Inc. 10%+ Owner Common Stock 49.3M $34.5M $0.70 Mar 5, 2025 Indirect
Surrozen, Inc./DE 10%+ Owner Common Stock 795K $9.23M $11.60 Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Common Stock 704K $8.17M $11.60 Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Common Stock 345K $4M $11.60 Mar 26, 2025 By The Column Group Opportunity III, LP
Tenaya Therapeutics, Inc. 10%+ Owner Series A Warrant (right to buy) 35.7M Mar 5, 2025 Indirect
Tenaya Therapeutics, Inc. 10%+ Owner Series B Warrant (right to buy) 17.9M Mar 5, 2025 Indirect
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 549K Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 517K Mar 26, 2025 By The Column Group Opportunity II, LP
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 486K Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 183K Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 172K Mar 26, 2025 By The Column Group Opportunity II, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 162K Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series B Common Warrants 112K Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series A Common Warrants 103K Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series B Common Warrants 98.9K Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series A Common Warrants 90.9K Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series C Common Warrants 0 Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series C Common Warrants 0 Mar 26, 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series D Common Warrants 0 Mar 26, 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series D Common Warrants 0 Mar 26, 2025 By The Column Group III, LP

Insider Reports Filed by Column Group III Gp, Lp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRZN Surrozen, Inc./DE Mar 26, 2025 21 $12M 4 Mar 28, 2025 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Mar 5, 2025 3 $25M 4 Mar 7, 2025 10%+ Owner
SRZN Surrozen, Inc./DE Apr 4, 2024 2 $3M 4/A Apr 17, 2024 10%+ Owner
SRZN Surrozen, Inc./DE Apr 4, 2024 10 $3M 4 Apr 8, 2024 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Feb 12, 2024 1 $10M 4 Feb 14, 2024 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Mar 10, 2023 1 $17.6K 4 Mar 14, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Feb 8, 2023 1 $3.9M 4 Feb 10, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jan 19, 2023 1 $174K 4 Jan 23, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jan 17, 2023 2 $465K 4 Jan 19, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Nov 21, 2022 1 $25M 4 Nov 23, 2022 10%+ Owner
SRZN Surrozen, Inc./DE Aug 11, 2021 0 $0 3 Aug 16, 2021 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Aug 3, 2021 8 $0 4 Aug 4, 2021 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner